Therefore, the vaccine’s alteration of the cytokine environment could lead to a change in T-cell repertoire in favor of a Th1 population, followed by the generation of new antibodies that stimulate the TSH receptor, possibly resulting in hyperthyroidism [69]. This evidence concerns the gene TSHR and hyperthyroidism.